AbbVie’s ABBV 2024 revenue grew 4.6% on a constant currency basis, with 2025 guidance of 5.7% growth and new 2027 guidance for combined sales of immunology drug Skyrizi and Rinvoq of $31 billion (up ...

Regardless of sociodemographic or clinical characteristics, children with food allergy face a significant psychosocial burden ...

A team of international researchers led by scientists at City of Hope have demonstrated a way to boost thymic function after ...

A recent study carried out by a research team from the Paul-Ehrlich-Institut investigated the immunomodulating properties of ...

In an increasingly interconnected world, global health faces constant threats from new and re-emerging pathogens. Recent devastating outbreaks of diseases ...

Significant racial disparities persisted in genetic testing for inborn errors of immunity despite the removal of financial barriers, according to a study published in The Journal of Allergy and ...

AbbVie Inc.'s stock rose 4% early Friday, after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025, as its newer immunology drugs delivered growth needed to ...

Plasma cells (PCs) are the terminal differentiation stage of activated B cells and serve as crucial effector cells in humoral immunity. While PCs have ...

A groundbreaking Japanese study finds a strong link between newborn gut bacteria and food allergies, suggesting probiotic ...

Dozens of medical experts have written an open letter to Alberta Premier Danielle Smith and Health Minister Adriana LaGrange ...